Safer pain treatment options for cancer survivors on long-term opioids

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 4 interventional trial will assign Veterans who are cancer survivors on long-term opioid therapy to one of four treatment strategies: multimodal pain care, medication optimization, buprenorphine rotation, or opioid tapering. The primary goal is to see which strategy or combination best reduces opioid use without worsening chronic pain over 6 and 9 months. Investigators will measure opioid dispensing and pain scores from electronic health records and collect implementation data on barriers and facilitators to delivering each approach within the VA. The project aims to produce practical care pathways that can be adopted across VA clinics to reduce opioid-related harms in this population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Veterans must have had a qualifying solid tumor (bladder, breast, colorectal, head and neck, liver, lung, pancreas, prostate, or urinary tract) without evidence of active disease for at least 6 months
* Participants must be 6 months away from their last receipt of cytotoxic, radiation, or surgical cancer treatments but can be on hormonal or biologic therapies needed to sustain remission or cancer control.
* Participants must report pain \>=4 (on 0-10 NRS) on their last 3 recordings in the electronic medical record. Veterans should be on Long Term Opioid Therapy (LTOT) defined as:

  * a qualifying opioid analgesic dispensed within the prior 30 days
  * plus 150 days' supply of a qualifying opioid (fentanyl, hydrocodone, hydromorphone, methadone, morphine, oxycodone, oxymorphone) in the 180 days before the most recent dispensing date with no between-fill gaps \>40 days
* There must be advance agreement from their existing opioid prescriber to resume opioid prescribing after study

Exclusion Criteria:

* Veterans with total daily opioid doses \>= 300 Morphine Milligram Equivalents (MME) will be excluded (higher doses require tapering prior to rotation to buprenorphine, which is something the investigators do not want to examine in this study)
* Veterans with referrals or visits to a substance abuse clinic within the prior 2 years will be excluded to avoid including individuals requiring addiction expertise that is not available one the multidisciplinary pain teams
* The investigators will also exclude Veterans with:

  * current or past use of buprenorphine
  * active alcohol use disorder or substance use
  * risk factors for opioid overdose (e.g. active suicidality or history of self-directed violence)
  * daily use of benzodiazepines
  * receipt of opioids from non-VA providers in the prior 3 months
  * or aberrant urine drug screen at baseline (cannabis is not exclusionary)
* To ensure the relevance of our work to as many Veteran cancer survivors as possible, the investigators will not exclude subjects meeting DSM criteria for opioid use disorder if their only source of opioids is the VA

Where it's running

• VA Ann Arbor Healthcare System, Ann Arbor, MI
  Ann Arbor, Michigan, United States Recruiting
• Richard L. Roudebush VA Medical Center, Indianapolis, IN
  Indianapolis, Indiana, United States Not yet recruiting

Study contacts

• Principal investigator: Karleen F Giannitrapani, PhD MA MPH — VA Palo Alto Health Care System, Palo Alto, CA
• Study coordinator: Maria J Silveira, MD MA MPH
• Email: Maria.Silveira2@va.gov
• Phone: (734) 845-3502

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Psilocybin-assisted psychotherapy to help taper long-term opioid pain medicines

  This pilot will try psilocybin-assisted psychotherapy to help adults with chronic noncancer pain who are on long-term opioid therapy reduce or stop their opioid medications.

  Recruiting Phase 2 University of British Columbia · Kelowna, British Columbia · NCT05585229

• Program to reduce opioid use in chronic pain patients after surgery

  This study is testing a new program to help chronic pain patients use less opioids after surgery by providing pain education and support tools.

  Recruiting University Health Network, Toronto · Toronto, Ontario · NCT03675386

• Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work

  This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.

  Recruiting at 2 sites Karolinska Institutet · Luleå, Norrbotten County and 2 other locations · NCT07924774

• One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital

  A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.

  Recruiting Ottawa Hospital Research Institute · Ottawa, Ontario · NCT07919626

• Meaning-Based Psychotherapy for Adults with Chronic Pain

  This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.

  Recruiting Hospital Clinico Universitario San Cecilio · Granada, Granada · NCT07915440

• How chronic pain changes over time in kids with Duchenne Muscular Dystrophy

  This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.

  Recruiting Antalya Training and Research Hospital · Antalya, Antalya · NCT07892196

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.